Detalhe da pesquisa
1.
Allogeneic natural killer cell therapy.
Blood
; 141(8): 856-868, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36416736
2.
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
Blood
; 139(8): 1177-1183, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34797911
3.
Weight of evidence evaluation of the metabolism disrupting effects of triphenyl phosphate using an expert knowledge elicitation approach.
Toxicol Appl Pharmacol
; : 116995, 2024 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38862081
4.
A modular strategy for the testing and assessment of non-genotoxic carcinogens.
Arch Toxicol
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38811392
5.
Avoiding a reproducibility crisis in regulatory toxicology-on the fundamental role of ring trials.
Arch Toxicol
; 98(7): 2047-2063, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689008
6.
Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
Br J Haematol
; 202(2): 248-255, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129856
7.
Increased Cell Proliferation as a Key Event in Chemical Carcinogenesis: Application in an Integrated Approach for the Testing and Assessment of Non-Genotoxic Carcinogenesis.
Int J Mol Sci
; 24(17)2023 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37686053
8.
The Cell Transformation Assay: A Historical Assessment of Current Knowledge of Applications in an Integrated Approach to Testing and Assessment for Non-Genotoxic Carcinogens.
Int J Mol Sci
; 24(6)2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36982734
9.
Use of New Approach Methodologies (NAMs) in regulatory decisions for chemical safety: Report from an EPAA Deep Dive Workshop.
Regul Toxicol Pharmacol
; 135: 105261, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36103951
10.
Analyses of Transcriptomics Cell Signalling for Pre-Screening Applications in the Integrated Approach for Testing and Assessment of Non-Genotoxic Carcinogens.
Int J Mol Sci
; 23(21)2022 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36361516
11.
Mechanistic Interrogation of Cell Transformation In Vitro: The Transformics Assay as an Exemplar of Oncotransformation.
Int J Mol Sci
; 23(14)2022 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35886950
12.
Dying for change: A roadmap to refine the fish acute toxicity test after 40 years of applying a lethal endpoint.
Ecotoxicol Environ Saf
; 223: 112585, 2021 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34365212
13.
Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.
Int J Mol Sci
; 22(20)2021 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34681626
14.
The use of ruxolitinib for acute graft-versus-host disease developing after solid organ transplantation.
Am J Transplant
; 20(2): 589-592, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31446673
15.
Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens.
Arch Toxicol
; 94(8): 2899-2923, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594184
16.
A comprehensive view on mechanistic approaches for cancer risk assessment of non-genotoxic agrochemicals.
Regul Toxicol Pharmacol
; 118: 104789, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33035627
17.
The GOLIATH Project: Towards an Internationally Harmonised Approach for Testing Metabolism Disrupting Compounds.
Int J Mol Sci
; 21(10)2020 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32423144
18.
Environmental pollution and COVID-19: the molecular terms and predominant disease outcomes of their sweetheart agreement.
Epidemiol Prev
; 44(5-6 Suppl 2): 169-182, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33412808
19.
The transformics assay: first steps for the development of an integrated approach to investigate the malignant cell transformation in vitro.
Carcinogenesis
; 39(7): 955-967, 2018 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29554273
20.
Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy.
Blood
; 137(13): 1832-1835, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33156925